What is Microcube?
MicroCube operates as a comprehensive, self-sufficient medical device company dedicated to identifying unmet clinical needs, pioneering breakthrough technologies, and delivering complete turnkey products and procedures for clinical application. The company concurrently manages five to ten cutting-edge projects, driven by multi-disciplinary teams of creative problem-solvers who have immediate access to all necessary capabilities within a single, integrated environment. Their in-house expertise spans diverse clinical practice knowledge, concept development, design, rapid prototyping, and intellectual property management, alongside market mapping, clinical trials, and regulatory submissions. MicroCube fosters a dynamic, self-enhancing culture that actively mentors designers, innovators, and leaders, empowering them to excel as specialists and executives in the device industry.
How much funding has Microcube raised?
Microcube has raised a total of $359K across 2 funding rounds:
Debt
$150K
Debt
$209K
Debt (2020): $150K with participation from PPP
Debt (2021): $209K led by PPP
Key Investors in Microcube
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Microcube?
With its recent strategic investment and substantial overall capital, Microcube is poised for accelerated growth and market penetration. The company's robust in-house capabilities, from initial concept to regulatory approval, provide a distinct advantage in bringing innovative medical devices to market efficiently. This late-stage funding will likely fuel the expansion of its project pipeline, enhance its research and development efforts, and support the scaling of its operations to meet increasing clinical demand. Microcube's focus on a self-enhancing culture also suggests a commitment to attracting and retaining top talent, crucial for sustained innovation and leadership in the medical device sector.
See full Microcube company page
